Jump to content

Talk:Recombinant human epidermal growth factor

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Aero-Plex (talk | contribs) at 15:00, 20 December 2013 (POV Issues: new section). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

POV Issues

This article has some very major POV issues. Some examples to get other editors going:

  • It's referred to as an "innovative biologic drug" directly in the article text.
  • This section is intended to make it seems like scientists in the USA are marginalizing the drug due to political issues, by attributing to the whole group a quote which is completely unattributed and cannot be used to represent the whole group, even if it were sourced to someone within said group: "The drug and clinical trials have been looked over by scientists in the USA, calling the drug "very clever", but the political situation..."

Unfortunately, I don't have the time right now or in the foreseeable future to draw up a better version, but I'll see what I can do. Aero-Plex (talk) 15:00, 20 December 2013 (UTC)[reply]